Shi, Yafei, Yanhui Li, Wei Chen, Mingyu Zhang, Di Qian, Taifeng Li, Yuanyuan Dai, and Guohui Li. “Cost-Effectiveness Analysis of Sintilimab Vs. Docetaxel As the Second-Line Therapy of Squamous Non-Small Cell Lung Cancer in China”. Health Decision 2, no. S1 (July 12, 2024). Accessed May 2, 2025. https://www.hksmp.com/journals/hd/article/view/653.